TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32327669

Group type: COMPARATOR
Intervention: Micro-dosing application of 30.75 kg N ha-1 and 34.5 kg P2O5 ha-1 (N applied in three splits: 1/3 at sowing, 1/3 at emergence, and 1/3 at 45 days after emergence) at Aybra.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Micro-dosing application of 20.5 kg N ha-1 and 23 kg P2O5 ha-1 (N applied in three splits: 1/3 at sowing, 1/3 at emergence, and 1/3 at 45 days after emergence) at Shumshiha-Lasta Lalibela.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recommended NP application of 41 kg N ha-1 and 46 kg P2O5 ha-1.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (without fertilizer).
Number of subjects: 0
Study: 36078324

Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Training (HIFT)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 33736592

Group type: EXPERIMENTAL
Intervention: Home-based exercises (resistance exercise, stretching, and aerobic exercise such as walking) for 6 months
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual-care group (stretching and usual physical activity)
Number of subjects: 53
Study: 34417673

Group type: EXPERIMENTAL
Intervention: Anti-beta-1-adrenergic receptor antibodies (anti-β1-AR) in patients with CCM
Number of subjects: 3
Study: 33047657

Group type: EXPERIMENTAL
Intervention: Professional Values Development Programme (12-week duration)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (received the programme after data collection)
Number of subjects: 80
Study: 32739716

Group type: EXPERIMENTAL
Intervention: Study Condition #1 (SC1) - accessed an online eHealth resource and generally available resources
Number of subjects: 217

Group type: COMPARATOR
Intervention: Study Condition #2 (SC2) - accessed only generally available resources
Number of subjects: 217
Study: 35788824

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering
Number of subjects: 300

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 300
Study: 35451351

Group type: EXPERIMENTAL
Intervention: VasQTM device
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (conventional surgery)
Number of subjects: 6
Study: 33218873

Group type: EXPERIMENTAL
Intervention: Brain Endurance Training (BET) group completed concurrent cognitive tasks (2-back, Stroop) during 24 submaximal hand contractions sessions over 6 weeks.
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group completed 24 submaximal hand contractions sessions over 6 weeks without concurrent cognitive tasks.
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: BET group compared to Control group regarding pre-frontal oxygenation during post-training physical tasks.
Number of subjects: 36
Study: 32878524

Group type: EXPERIMENTAL
Intervention: Timetabled primary care sessions in all three clinical years
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Enrolling in rural medical student recruitment schemes
Number of subjects: 390

Group type: EXPERIMENTAL
Intervention: Valuing core values of GP
Number of subjects: 390
Study: 33310604

Group type: EXPERIMENTAL
Intervention: Meditation program involving daily use of the 'Muse' device for eight weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 71
Study: 33247008

Group type: EXPERIMENTAL
Intervention: 3D-printed brace
Number of subjects: 88

Group type: COMPARATOR
Intervention: TLSO (thoracolumbosacral orthoses)
Number of subjects: 88
Study: 35183257

Group type: EXPERIMENTAL
Intervention: Early-support intervention (eight-component support including training, sharing of experience, audit-and-feedback, and resource support)
Number of subjects: 43054
Study: 32889444

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Relapse Prevention (MBRP)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Relapse Prevention (RP)
Number of subjects: 221
Study: 33072380

Group type: EXPERIMENTAL
Intervention: Intradialytic progressive resistance exercise (IPRE)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group (haemodialysis session alone)
Number of subjects: 87
Study: 35260292

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT) by telephone
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Yoga (in-person group classes)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Randomized controlled trial (RCT) of CBT or yoga
Number of subjects: 500

Group type: COMPARATOR
Intervention: Preference trial (selected CBT or yoga)
Number of subjects: 500
Study: 33720893

Group type: EXPERIMENTAL
Intervention: Aerobic training (n=13)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Balance and toning (BAT) control group (n=14)
Number of subjects: 27
Study: 32789664

Group type: EXPERIMENTAL
Intervention: Response-oriented feedback
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Conceptually focused feedback
Number of subjects: 64

Group type: COMPARATOR
Intervention: Right/wrong feedback
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Initial test occasion
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Far transfer tasks
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Near transfer tasks
Number of subjects: 64
Study: 35029231

Group type: EXPERIMENTAL
Intervention: Intermittent theta burst stimulation (iTBS)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 47
Study: 33556861

Group type: EXPERIMENTAL
Intervention: Modular cognitive behavioral intervention delivered by trained healthcare professionals (HCPs) over 6 months
Number of subjects: 34
Study: 32103319

Group type: EXPERIMENTAL
Intervention: Two whole apples daily for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sugar and energy-matched control beverage
Number of subjects: 40
Study: 34558768

Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 or 25 mg)
Number of subjects: 7020
Study: 34240673

Group type: EXPERIMENTAL
Intervention: Risedronate (35 mg/week)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Menopausal hormone therapy (MHT) - estradiol gel (1.5 mg/day) + oral micronized progesterone (100 mg/day)
Number of subjects: 281
Study: 32434932

Group type: EXPERIMENTAL
Intervention: Ecologic Femi+ (EF+) vaginal capsule
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Gynophilus LP (GynLP) vaginal tablet
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Oral metronidazole
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Behavioural counselling only
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Overall adherence and acceptability of probiotics
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Vaginal washing practices
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Sexual risk behaviours
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Knowledge about vaginal infections
Number of subjects: 68
Study: 35455518

Group type: EXPERIMENTAL
Intervention: Mother‐Infant Transaction Program‐Modified (MITP‐M, n = 72)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Preterm control group (n = 74)
Number of subjects: 146
Study: 32347764

Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas stoves and fuel
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Stove use monitors (Geocene)
Number of subjects: 3200

Group type: EXPERIMENTAL
Intervention: Ambient air monitoring
Number of subjects: 3200
Study: 35105307

Group type: EXPERIMENTAL
Intervention: Topical local anesthesia with EMLA®
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sterile water injections without topical local anesthesia (Control group 1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Isotonic saline 0.9% with topical local anesthesia (Control group 2)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Isotonic saline 0.9% without topical local anesthesia (Control group 3)
Number of subjects: 120
Study: 33121861

Group type: EXPERIMENTAL
Intervention: Music therapy (preferred genre played during treatment)
Number of subjects: 102

Group type: COMPARATOR
Intervention: No music (control group)
Number of subjects: 102
Study: 35125224

Group type: EXPERIMENTAL
Intervention: MAS-1 adjuvanted IIV (0.3 mL, 9 µg per HA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: MAS-1 adjuvanted IIV (0.5 mL, 9 µg per HA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: High dose IIV (Fluzone HD, 60 µg per HA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: MAS-1 adjuvanted IIV
Number of subjects: 45
Study: 33777428

Group type: EXPERIMENTAL
Intervention: Falls among elderly individuals
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Gender comparison of falls
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Location of falls
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Age risk factor
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Polypharmacy risk factor
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Environmental factors risk factor
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Education level risk factor
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: MAHC‐10 fall risk score
Number of subjects: 269
Study: 32267783

Group type: EXPERIMENTAL
Intervention: Apnea training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control
Number of subjects: 40
Study: 34713471

Group type: EXPERIMENTAL
Intervention: Systemic metronidazole
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 34237655

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SMO) 0.75, 1.25, 1.75 or 2.25 g t.i.d. for 12 weeks
Number of subjects: 509

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 509
Study: 34617955

Group type: EXPERIMENTAL
Intervention: Fulvestrant-Palbociclib
Number of subjects: 486

Group type: COMPARATOR
Intervention: Letrozole-Palbociclib
Number of subjects: 486
Study: 32478616

Group type: EXPERIMENTAL
Intervention: 1.5 cm shoe lift on the non-affected lower limb
Number of subjects: 42

Group type: COMPARATOR
Intervention: No shoe lift
Number of subjects: 42
Study: 33799341

Group type: EXPERIMENTAL
Intervention: Ischemic compression of the first dorsal interosseous muscle trigger points (MTrPs)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham treatment of the first dorsal interosseous muscle trigger points (MTrPs)
Number of subjects: 31
Study: 34867113

Group type: EXPERIMENTAL
Intervention: Comprehensive nursing intervention for 2 months on top of routine intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine radiotherapy and chemotherapy with routine nursing intervention
Number of subjects: 100
Study: 32563606

Group type: EXPERIMENTAL
Intervention: Bivalent VLP vaccine with MPL
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Bivalent VLP vaccine without MPL
Number of subjects: 294

Group type: COMPARATOR
Intervention: Placebo (one dose)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Bivalent VLP vaccine (one dose)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Bivalent VLP vaccine (two doses)
Number of subjects: 294
Study: 34698676

Group type: EXPERIMENTAL
Intervention: Medical thoracoscopy (MT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rigid mini-thoracoscopy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pleural cryobiopsy
Number of subjects: 0
Study: 34551681

Group type: EXPERIMENTAL
Intervention: Educational intervention group (oral presentation by CPCC and distribution of gift packages)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 336
Study: 33186448

Group type: EXPERIMENTAL
Intervention: Orthostatic Hypotension (OH)
Number of subjects: 897
Study: 32195749

Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) kits for secondary distribution offered to individuals aged 18 years and older.
Number of subjects: 9105

Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) kits for secondary distribution.
Number of subjects: 9105
Study: 36129712

Group type: EXPERIMENTAL
Intervention: MyPEEPS Mobile intervention (21 online psychoeducational and skill-building modules over 3 months)
Number of subjects: 763

Group type: COMPARATOR
Intervention: Delayed intervention (access to MyPEEPS Mobile at 9-month visit)
Number of subjects: 763

Group type: EXPERIMENTAL
Intervention: MyPEEPS Mobile intervention
Number of subjects: 763
Study: 32674126

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 800 mg on day 1 followed by 400 mg once daily for 6 days
Number of subjects: 293

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 293
Study: 32153050

Group type: EXPERIMENTAL
Intervention: Topical lidocaine 10% spray
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral dapoxetine 60 mg
Number of subjects: 0
Study: 33901635

Group type: EXPERIMENTAL
Intervention: C/N 15:1 bioflocs
Number of subjects: 360

Group type: COMPARATOR
Intervention: C/N 20:1 bioflocs
Number of subjects: 360

Group type: COMPARATOR
Intervention: Commercial diet (control)
Number of subjects: 360
Study: 33583424

Group type: EXPERIMENTAL
Intervention: Web-based decision aid on relapse management, nurse-led webinar, and access to a monitored chat forum
Number of subjects: 188

Group type: COMPARATOR
Intervention: Standard information via the same online platform
Number of subjects: 188
Study: 36368240

Group type: EXPERIMENTAL
Intervention: Vibratory unloader knee orthosis
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conventional knee orthosis
Number of subjects: 14
Study: 34463398

Group type: EXPERIMENTAL
Intervention: Laughter therapy applied twice a week for 4 weeks
Number of subjects: 61

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 61
Study: 32977565

Group type: EXPERIMENTAL
Intervention: Mixed energy supply algorithm based on matching game and convex optimization
Number of subjects: 0
Study: 35697040

Group type: EXPERIMENTAL
Intervention: Pembrolizumab or nivolumab
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (nonautoimmune patients)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Autoimmune group
Number of subjects: 77

Group type: COMPARATOR
Intervention: Nonautoimmune group
Number of subjects: 77
Study: 34375320

Group type: EXPERIMENTAL
Intervention: Hydroxyapatite chip bone (Group A)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Allogenic chip bone (Group B)
Number of subjects: 97

Group type: COMPARATOR
Intervention: No bone graft (Group C)
Number of subjects: 97
Study: 32917221

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299v (Sanprobi IBS®)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 35830482

Group type: EXPERIMENTAL
Intervention: Ad libitum feeding without calcium salts of palm oil (ANF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ad libitum feeding with calcium salts of palm oil (AWF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Restricted feeding without calcium salts of palm oil (RNF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Restricted feeding with calcium salts of palm oil (RWF)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ad libitum feeding after restriction
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Plasma GIP concentration
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Correlation of GIP with RQ
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Insulin correlation with GIP and RQ
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Association between GIP and marbling score (MS)
Number of subjects: 60
Study: 34479761

Group type: EXPERIMENTAL
Intervention: Ketoprofen plaster 30 mg twice daily (n = 118)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Diclofenac plaster 15 mg once daily (n = 118)
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Ketoprofen plaster 30 mg twice daily
Number of subjects: 236

Group type: COMPARATOR
Intervention: Diclofenac plaster 15 mg once daily
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Knee Injury and Osteoarthritis Outcome Score
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Frequency of rescue medication use
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Adverse event profile
Number of subjects: 236
Study: 36018846

Group type: EXPERIMENTAL
Intervention: Ecological Momentary Assessment and Intervention (EMAI) using a smartphone-based application over a 90-day period.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ecological Momentary Assessment (EMA)
Number of subjects: 50
Study: 34099584

Group type: EXPERIMENTAL
Intervention: High-fat load (150 g of fat at time 0)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-fat load with fructose (three doses of 50 g at 0, 2, and 4 hours)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-fat load with glucose (three doses of 50 g at 0, 2, and 4 hours)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Fasting
Number of subjects: 8
Study: 32827709

Group type: EXPERIMENTAL
Intervention: Inspiratory resistive loading (IRL) at 15 cmH2O
Number of subjects: 9

Group type: COMPARATOR
Intervention: Passive recovery (CON)
Number of subjects: 9
Study: 34968821

Group type: EXPERIMENTAL
Intervention: Information received from health professionals (face to face through childbirth education or midwife discussion/education)
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: Information from friends and family members
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: Internet as a source of information
Number of subjects: 1034

Group type: EXPERIMENTAL
Intervention: Trusted and reliable sources of information
Number of subjects: 1034
Study: 34367541

Group type: EXPERIMENTAL
Intervention: BPNN artificial intelligence algorithm for ultrasound image segmentation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Routine ultrasound diagnosis
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: BPNN artificial intelligence algorithm
Number of subjects: 90
Study: 36269938

Group type: EXPERIMENTAL
Intervention: HepB-CpG (HEPLISAV-B®)
Number of subjects: 155

Group type: COMPARATOR
Intervention: HepB-Eng (Engerix-B®)
Number of subjects: 155

Group type: COMPARATOR
Intervention: HepB-AS04 (Fendrix®)
Number of subjects: 155
Study: 32808736

Group type: EXPERIMENTAL
Intervention: Percutaneous transluminal septal myocardial ablation (PTSMA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 10
Study: 33084335

Group type: EXPERIMENTAL
Intervention: Polyphenol-rich foods
Number of subjects: 0
Study: 35673850

Group type: EXPERIMENTAL
Intervention: Maternal infant-directed reading intervention
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 67
Study: 33033967

Group type: EXPERIMENTAL
Intervention: FM50Fu diet group (fucoidan supplemented with 50% FM replacement)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: FM25Fu diet group (fucoidan supplemented with 25% FM replacement)
Number of subjects: 3

Group type: COMPARATOR
Intervention: FM-based control diet (FM diet)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: FM75 diet group (75% FM replacement, no fucoidan)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Fucoidan-supplemented groups (D2, D3, D4, D5, D6, D7)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Fucoidan-supplemented diets
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Fucoidan-supplemented groups
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: FM75Fu diet group (fucoidan supplemented with 75% FM replacement)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Interaction effects of fucoidan and FM replacement level
Number of subjects: 3
Study: 36029465

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 6263
Study: 33952245

Group type: EXPERIMENTAL
Intervention: Group behavior therapy knowledge, attitude, and beliefs assessment
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Previous attempts to quit smoking
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Number of cigarettes used per day
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Level of education
Number of subjects: 229
Study: 33892671

Group type: EXPERIMENTAL
Intervention: EPIC program (intervention with peer recovery supporter, family treatment drug court, medications for opioid use disorders, home-based parenting supports)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: EPIC program (intervention)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Comparison groups (Ohio START and treatment as usual)
Number of subjects: 750
Study: 32643884

Group type: EXPERIMENTAL
Intervention: Electrical stimulation with bilateral scalp acupuncture
Number of subjects: 84

Group type: COMPARATOR
Intervention: Acupuncture based on acupoint selection for pseudobulbar palsy (Control)
Number of subjects: 84
Study: 35613385

Group type: EXPERIMENTAL
Intervention: Dairy-free diet for mothers during the first 14 days after the newborn's onset of feeding
Number of subjects: 120

Group type: COMPARATOR
Intervention: No special diet given to mothers
Number of subjects: 120
Study: 33150514

Group type: EXPERIMENTAL
Intervention: Anodal trans-cranial direct current stimulation (a-tDCS) + Functional Electrical Stimulation (FES)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham tDCS + Functional Electrical Stimulation (FES)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (20-min FES only)
Number of subjects: 32
Study: 32962055

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 0

Group type: COMPARATOR
Intervention: Episiotomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No perineal tears
Number of subjects: 0

Group type: COMPARATOR
Intervention: Greater parity
Number of subjects: 0
Study: 34018031

Group type: EXPERIMENTAL
Intervention: HIIT (High-Intensity Interval Training) group attended sessions three days per week for eight weeks.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group maintained current level of physical activity.
Number of subjects: 30
Study: 32813610

Group type: EXPERIMENTAL
Intervention: Nelarabine
Number of subjects: 1562

Group type: COMPARATOR
Intervention: No nelarabine
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: C-MTX plus nelarabine
Number of subjects: 1562
Study: 35332811

Group type: EXPERIMENTAL
Intervention: Self-paced treadmill walking
Number of subjects: 25

Group type: COMPARATOR
Intervention: Overground walking
Number of subjects: 25
Study: 34884273

Group type: EXPERIMENTAL
Intervention: Scenar-On group (active treatment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Scenar-Off group (sham treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60